Insider holders · CIK 0001367083
Sonoma Pharmaceuticals, Inc. · SNOA
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Jay E BirnbaumDirector | 51,659 | — | 51,659 | Jun 1, 2018 · 8:28 pm EDT | Form 4 |
| John McLaughlinDirector | 48,728 | — | 48,728 | Jun 1, 2018 · 8:30 pm EDT | Form 4 |
| Russell Joseph HarrisonDirector | 46,520 | — | 46,520 | Jun 1, 2018 · 8:30 pm EDT | Form 4 |
| Sharon Surrey BarbariDirector | 43,417 | — | 43,417 | Mar 2, 2018 · 7:13 pm EST | Form 4 |
| Robert E Millerrelationship not stated | 20,800 | 18,868 | 39,668 | Jan 15, 2019 · 7:16 pm EST | Form 4 |
| James J Schutzrelationship not stated | 35,858 | — | 35,858 | Jan 15, 2019 · 7:17 pm EST | Form 4 |
| Philippe WeigerstorferDirector | 22,500 | — | 22,500 | Sep 21, 2018 · 4:35 pm EDT | Form 3 |
| Robert Allen NortheyExe. VP of Research and Dev. | 8,082 | — | 8,082 | Jun 30, 2017 · 4:18 pm EDT | Form 4 |
| Marc UmscheidChief Strategy/Mkt Officer | 3,392 | — | 3,392 | Aug 11, 2017 · 4:10 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.